Inventor · disambiguated record
Philip Glyn Jones
Also filed as: JONES PHILIP G · JONES PHILIP GLYN
9 granted patents·4 pending applications·19 citations·filing 2013–2024
83Inventor score
Files withSUNOVION PHARMACEUTICALS INC8SUMITOMO PHARMA AMERICA INC2SUNOVION PHARAMACEUTICALS INC2PGI DRUG DISCOVERY LLC1
Top patents by PatentIndex Score
13 records- 0191US10196403B2Compounds and compositions and uses thereofSUNOVION PHARMACEUTICALS INC·Filed 2017·Granted Feb 5, 2019·8 cites·44 claims
- 0289US10336732B21-heterocyclyl isochromanyl compounds and analogs for treating CNS disordersSUNOVION PHARMACEUTICALS INC·Filed 2017·Granted Jul 2, 2019·7 cites·20 claims
- 0381US2024409550A1Compounds and compositions and uses thereofSUMITOMO PHARMA AMERICA INC·Filed 2024·Application pending·0 cites
- 0479US9856238B21-heterocyclyl isochromanyl compounds and analogs for treating CNS disordersSUNOVION PHARMACEUTICALS INC·Filed 2016·Granted Jan 2, 2018·2 cites·33 claims
- 0573US10927124B2Compounds and compositions and uses thereofPGI DRUG DISCOVERY LLC·Filed 2018·Granted Feb 23, 2021·1 cites·26 claims
- 0673US2022185799A11-heterocyclyl isochromanyl compounds and analogs for treating cns disordersSUNOVION PHARMACEUTICALS INC·Filed 2021·Application pending·0 cites
- 0770US11958862B2Compounds and compositions and uses thereofSUMITOMO PHARMA AMERICA INC·Filed 2021·Granted Apr 16, 2024·0 cites·34 claims
- 0869US11192885B21-heterocyclyl isochromanyl compounds and analogs for treating CNS disordersSUNOVION PHARMACEUTICALS INC·Filed 2019·Granted Dec 7, 2021·0 cites·24 claims
- 0969US9994590B2Substituted [1,2,4]triazolo[1,5-a]pyrazines as phosphodiesterase inhibitorsSUNOVION PHARAMACEUTICALS INC·Filed 2016·Granted Jun 12, 2018·1 cites·25 claims
- 1058US10604536B2Substituted cyclopropanes as PDE-10 inhibitorsSUNOVION PHARAMACEUTICALS INC·Filed 2018·Granted Mar 31, 2020·0 cites·25 claims
- 1155US2023241024A1Methods of treating metabolic disordersSUNOVION PHARMACEUTICALS INC·Filed 2022·Application pending·0 cites
- 1247US9951088B2D2 receptor modulators and methods of use thereof in the treatment of diseases and disordersSUNOVION PHARMACEUTICALS INC·Filed 2013·Granted Apr 24, 2018·0 cites·16 claims
- 1345US2019031685A1Heteroaryl compounds and methods of use thereofSUNOVION PHARMACEUTICALS INC·Filed 2018·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Philip Glyn Jones files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →